Medications

Jury orders Gilead to pay Merck $2.5bn in patent case

A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.

Diseases, Conditions, Syndromes

Fighting life-threatening bacteria without antibiotics

Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. Scientist at the University of Bonn and TU Munich ...

Diseases, Conditions, Syndromes

Modified protein reverses cirrhosis in lab rats

A protein modified to increase the amount of time it circulates in the bloodstream appears to reverse liver fibrosis and cirrhosis in rats, according to results of a study led by Johns Hopkins researchers.

Diseases, Conditions, Syndromes

Pre-op fasting times often exceed guidelines in cirrhosis

(HealthDay)—For patients who have hepatic cirrhosis or have undergone liver transplantation, medically ordered pre-procedural fasting times frequently exceed existing guidelines, according to a study published online Jan. ...

Diseases, Conditions, Syndromes

Low-dose rifaximin cuts endotoxin level in cirrhosis

(HealthDay)—For patients with liver cirrhosis, low-dose rifaximin is comparable to high-dose rifaximin for reducing serum endotoxin levels, according to a study published online Oct. 16 in the Journal of Digestive Diseases.

Diseases, Conditions, Syndromes

Liver damage in hepatitis C patients significantly underestimated

The number of hepatitis C patients suffering from advanced liver damage may be grossly underestimated and underdiagnosed, according to a study led by researchers at Henry Ford Health System and the U.S. Centers for Disease ...

Diseases, Conditions, Syndromes

Technivie approved for hepatitis C

(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without poor liver ...

page 5 from 11